The total return over the past 12 months is -67.38% vs. +16.94% for the S&P 500. So far it's up +27.93% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (67.38%) | (67.99%) | (60.09%) | N/A | N/A | N/A |
| Total Return CAGR | (67.38%) | (67.99%) | (60.09%) | N/A | N/A | N/A |
| Revenue CAGR | (148.19%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
DNA X, Inc. (SONM)
| Year | Start price | End price | SONM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.15 | $4.03 | +27.93% | +14.51% | +13.42% |
| 2025 | $56.79 | $3.15 | (94.45%) | +17.72% | (112.17%) |
| 2024 | $132.28 | $56.79 | (57.07%) | +24.89% | (81.96%) |
| 2023 | $76.46 | $132.28 | +73.01% | +26.19% | +46.82% |
| 2022 | $165.92 | $76.46 | (53.92%) | (18.17%) | (35.75%) |
| 2021 | $1,303.20 | $165.92 | (87.27%) | +28.74% | (116.01%) |
| 2020 | $6,534.00 | $1,303.20 | (80.06%) | +18.37% | (98.43%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
